United Health Products, Inc. Uplists Shares to OTCQB Venture Market Amid FDA Progress
United Health Products, Inc. successfully uplists shares to OTCQB Venture Market, signaling progress towards FDA approval for CelluSTAT Hemostatic Gauze. CEO Brian Thom highlights benefits of increased visibility and liquidity.
This news signifies a positive development for United Health Products, Inc. as it aims to expand its reach and enhance trading liquidity. The company's advancement towards FDA approval for its innovative Hemostatic Gauze could potentially revolutionize the medical technology sector, offering a natural solution for controlling bleeding.